Lamotrigine—A Review of Analytical Methods Developed for Pharmaceutical Formulations and Biological Matrices. (3rd October 2022)

• Record Type: Journal Article
• Authors: S, Sajeeda; Kumar, Lalit; Verma, Ruchi
• Is Part Of: Critical reviews in analytical chemistry. Volume 52:Number 7(2022)
• Page Start: 1451
• Page End: 1460
• Publication Date: 2022-10-03
• Subjects: Biological matrices -- Lamotrigine -- pharmaceutical formulations; Chemistry, Analytic -- Periodicals; 543
• DOI: 10.1080/10408347.2021.1886901
• Languages: English
• ISSNs: 1040-8347

Abstract

Abstract: Lamotrigine owing to its excellent inhibitory property of neurotransmitter release especially glutamate is used in the treatment of epilepsy as a second-line antiepileptic drug. It differs from other antiepileptic drugs chemically and pharmacologically and is used as both monotherapy and adjunct therapy in the treatment of epilepsy. The present review focuses on two aspects (a) various analytical methods used in quantification of Lamotrigine in pharmaceutical formulations and (b) various analytical methods used to determine Lamotrigine in biological matrices. Here the various analytical methods are developed using different parameters and validation of employed methods is discussed. Estimated parameters like the linearity, LOD (Limit of detection) and LOQ (Limit of quantification) of validation are discussed for the individual method. The critical quality attributes like the wavelength of detection, mobile phase, columns, flow rate, retention time, and the sample preparation methods for the estimation of Lamotrigine by bioanalytical methods are also discussed.